TBX4 and pulmonary arterial hypertension: Whilst early reports indicated a milder presentation in some PAH patients, it is now recognised that the clinical phenotypes associated with TBX4 disruption represent a broad spectrum, ranging from transient neonatal PH to severe developmental lung disorders and progressive or biphasic PH, which may be associated with skeletal, cardiac and/or neurological anomalies.